Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists

Hundreds Contact BBC About ‘Hell’ Skin Condition, But Doctors Disagree on Its Existence

Two weeks ago, a BBC News piece explored the growing concern around a challenging skin condition, termed topical steroid withdrawal (TSW), which has sparked discussions across social media platforms. For some individuals, it represents a severe form of eczema, while others view it as a distinct ailment. However, medical professionals remain divided on its classification. The piece generated significant response, with millions of readers engaging and 240 individuals reaching out to share their experiences. What is causing this widespread debate?

A Mother’s Struggle and a Daring Choice

Bethany Norman, a 36-year-old mother, recalls holding her newborn son in hospital while her arms were covered in bandages. She had been diagnosed with eczema but refused to apply steroid creams, citing her own adverse reaction. “Look at what this medication has done to me? Why would I use it on my own child?” she remembers shouting. Her belief was that the creams, prescribed for her lifelong eczema, had triggered TSW. At the time, her skin was plagued by open wounds, an intense, bone-deep itch, and relentless flaking. She described feeling trapped within her own body.

“I’ve been told by countless medics that all I have is a severe flare-up of eczema and steroid creams will fix it. They just made it worse.”

Topical steroid creams have been a staple in dermatology since the 1950s, aiding millions in managing eczema and leading normal lives. These range from mild hydrocortisone available over-the-counter to stronger formulations requiring a prescription. Yet, a faction of patients argue these treatments no longer suffice for them. This has led to tension between patients and healthcare providers, as some feel their symptoms are not adequately addressed.

Medical Professionals’ Dilemma

In 2021, the MHRA, the UK’s regulatory body for medicines, acknowledged TSW as a reaction to prolonged steroid cream use—but not as a formally diagnosed condition. Without clear diagnostic criteria, confusion persists. Dr. Pippa Bowes, an urgent care physician specializing in acute dermatology, notes that communication gaps often arise. “Patients may feel unheard, and some professionals struggle to grasp the complexity of their symptoms.”

Jenna Crosbie, a trainee GP in north Wales, initially found it perplexing that a patient like Bethany would avoid steroid creams. Her medical training emphasized these as first-line treatments for eczema, and she had relied on them for years. However, during her time in A&E, she encountered a case that mirrored her own evolving experience. “I saw a patient with what seemed like the worst eczema I’d ever seen, yet they were rejecting steroids,” she reflects. After researching and noticing her symptoms deviated from typical eczema, Crosbie opted to discontinue use, a decision her GP supported.

“I wouldn’t wish this condition on my worst enemy,” Crosbie says.

Dr. Dean Eggit, a GP in Doncaster, raises concerns about overuse of steroid creams. He explains that GPs often prescribe them based on visual cues, such as redness, without fully investigating underlying causes. “The early stages of TSW can resemble the original eczema rash, so there’s a risk of reinforcing the condition with continued cream application.”

Guidelines and the Search for Solutions

The National Institute for Health and Clinical Excellence (NICE) recommends a gradual approach to eczema treatment, starting with emollients before introducing steroids. However, this method relies on regular monitoring. Dr. Adrian Hayter, from the Royal College of GPs, highlights the need for follow-ups to ensure steroids are not being used excessively. “If a patient is on a repeat prescription, we must verify their progress and adjust as necessary,” he states.

As research into TSW expands, the divide between patients and doctors continues. While some see it as a reaction, others argue it’s a legitimate condition. The lack of consensus leaves many questioning whether treatment protocols might inadvertently worsen the issue. For now, the mystery endures, with both sides seeking clarity in the face of shared suffering.